Simvastatin + clarithromycin
Simvastatin + Clarithromycin
Simvastatin exposure may rise with Clarithromycin
Can you check whether this combination could raise muscle pain or muscle injury risk?
Simvastatin exposure may rise with Clarithromycin
Clarithromycin may increase Simvastatin exposure, raising Simvastatin toxicity review priority. Related pathway, metabolite, and evidence signals are grouped below.
fda label · 8 sources · mechanistic high · authority-linked
- ev_simvastatin_label_cyp3a4Simvastatin (Zocor) Prescribing Information — Contraindicated and dose-limited interactions
- PMID 12036392Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
- PMID 26367500Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid
- PMID 35152405CPIC Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms